Regenerative Medicine Foundation
  • Leadership
  • What We Do
    • Our Event History
    • Policy
    • Advocacy
    • Education & Outreach
  • Events
    • Upcoming Events
    • Past Events
      • World Stem Cell Summit
      • Regenerative Medicine and Stem Cell Action Awards
      • Regenerative Medicine Essentials
      • The “Art of Science” Inspires Students
      • Exploring Public Policy: Regenerative Medicine and Cell Therapies
      • Congressional Briefings
      • World Stem Cell Summit – CHINA
  • Membership/Register
    • Membership
    • Amazon SMILE
  • News
    • News
    • Portraits of Hope
    • Video
    • Video Chats
  • Contact
  • Donate
Select Page
Longeveron Selected to Present at the 2021 World Stem Cell Summit Dr. Joshua Hare, Longeveron’s Chief Science Officer, to present during this year’s Longevity Session

Longeveron Selected to Present at the 2021 World Stem Cell Summit Dr. Joshua Hare, Longeveron’s Chief Science Officer, to present during this year’s Longevity Session

by Admin | Apr 28, 2021 | News & Opinions

MIAMI, April 27, 2021 (GLOBE NEWSWIRE) — Longeveron Inc. (NASDAQ: LGVN) (“Longeveron” or “Company”), a clinical stage biotechnology company developing cellular therapies for chronic, aging-related and life-threatening conditions,...
Breakthrough Paper Outlines Path to Heart Regeneration After Cardiac Injury

Breakthrough Paper Outlines Path to Heart Regeneration After Cardiac Injury

by Admin | Apr 27, 2021 | News & Opinions

ALACHUA, Fla. (PRWEB)April 21, 2021 – Cardiovascular disease kills more than 650,000 Americans annually.(1) Those who survive myocardial infarction remain at risk of death because the human heart has a very limited ability to repair itself. No one has yet found...
Advancing the Development of Safe and Effective Regenerative Medicine Products

Advancing the Development of Safe and Effective Regenerative Medicine Products

by Admin | Apr 23, 2021 | News & Opinions

By: Peter Marks, M.D., Ph.D., Director, Center for Biologics Evaluation and Research Link to article The U.S. Food and Drug Administration plays a vital role in facilitating the development and availability of innovative medical products. Products such as...
Clinical trial assesses stem cells’ ability to prevent major cause of preemie deaths

Clinical trial assesses stem cells’ ability to prevent major cause of preemie deaths

by Admin | Apr 20, 2021 | News & Opinions

Durham, NC – A phase 2 clinical trial whose results were released today in STEM CELLS Translational Medicine might point to a way to overcome bronchopulmonary dysplasia (BPD), a major cause of death in preterm infants. The study, conducted by researchers at...
Fat grafts enhanced with ADSCs show promise in treating facial scleroderma

Fat grafts enhanced with ADSCs show promise in treating facial scleroderma

by Admin | Apr 19, 2021 | News & Opinions

Durham, NC – A study released today in STEM CELLS Translational Medicine suggests a new way to correct facial atrophy of localized scleroderma (LoS) in patients. It shows how applying grafts made up of the patient’s own fat enhanced with adipose‐derived stem cells...
Page 37 of 77« First«363738»Last »

Recent Posts

  • What will be born of the marriage of de-extinction firm Colossal and animal cloning biotech Viagen?
  • SwRI-developed single-use 3D-printed bioreactor harvests induced Pluripotent Stem Cells
  • Technical University of Munich transforms stem cells into bone cells
  • Japanese Researchers Develop Method to Repair Spinal Fractures Using Fat-Derived Stem Cells
  • Scientists see foam as starting point of a path to bedside gene therapy
Tweets about @WSCSummit